BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 11434882)

  • 1. [Primary immunodeficiencies. Clinical features and variant forms].
    Fontán Casariego G
    Allergol Immunopathol (Madr); 2001; 29(3):101-7. PubMed ID: 11434882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Late onset of primary immune deficiencies].
    Bussone G; Mouthon L
    Presse Med; 2010 Feb; 39(2):196-207. PubMed ID: 19481902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
    Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
    J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunodeficiencies: an overview and various diagnostic difficulties].
    Fontán Casariego G
    Sangre (Barc); 1999 Apr; 44(2):101-6. PubMed ID: 10382319
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular genetics of X-linked primary immunodeficiencies: advances in diagnosis and prevention].
    Carbonara A; Brusco A; Carbonara C
    Ann Ital Med Int; 1996; 11(3):180-6. PubMed ID: 8998263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary immunodeficiencies (PIDs) presenting with cytopenias.
    Notarangelo LD
    Hematology Am Soc Hematol Educ Program; 2009; ():139-43. PubMed ID: 20008192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for inherited immunodeficiency.
    Touzot F; Hacein-Bey-Abina S; Fischer A; Cavazzana M
    Expert Opin Biol Ther; 2014 Jun; 14(6):789-98. PubMed ID: 24823313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for PIDs: progress, pitfalls and prospects.
    Mukherjee S; Thrasher AJ
    Gene; 2013 Aug; 525(2):174-81. PubMed ID: 23566838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary complications of primary immunodeficiencies.
    Buckley RH
    Paediatr Respir Rev; 2004; 5 Suppl A():S225-33. PubMed ID: 14980276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked immunodeficiencies.
    Ochs HD; Notarangelo LD
    Curr Allergy Asthma Rep; 2004 Sep; 4(5):339-48. PubMed ID: 15283872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of primary immunodeficiency disorders in Australia.
    Baumgart KW; Britton WJ; Kemp A; French M; Roberton D
    J Allergy Clin Immunol; 1997 Sep; 100(3):415-23. PubMed ID: 9314356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current perspectives on primary immunodeficiency diseases.
    Kumar A; Teuber SS; Gershwin ME
    Clin Dev Immunol; 2006; 13(2-4):223-59. PubMed ID: 17162365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral vectors for the treatment of primary immunodeficiencies.
    Farinelli G; Capo V; Scaramuzza S; Aiuti A
    J Inherit Metab Dis; 2014 Jul; 37(4):525-33. PubMed ID: 24619149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Spanish Registry of Primary Immunodeficiencies (REDIP)].
    Milá Llambí J; Etxagibel Galdos A; Matamoros Florí N
    Allergol Immunopathol (Madr); 2001; 29(3):122-5. PubMed ID: 11434886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical and Genetic Spectrum of 82 Patients With
    Sharapova SO; Skomska-Pawliszak M; Rodina YA; Wolska-Kuśnierz B; Dabrowska-Leonik N; Mikołuć B; Pashchenko OE; Pasic S; Freiberger T; Milota T; Formánková R; Szaflarska A; Siedlar M; Avčin T; Markelj G; Ciznar P; Kalwak K; Kołtan S; Jackowska T; Drabko K; Gagro A; Pac M; Naumova E; Kandilarova S; Babol-Pokora K; Varabyou DS; Barendregt BH; Raykina EV; Varlamova TV; Pavlova AV; Grombirikova H; Debeljak M; Mersiyanova IV; Bondarenko AV; Chernyshova LI; Kostyuchenko LV; Guseva MN; Rascon J; Muleviciene A; Preiksaitiene E; Geier CB; Leiss-Piller A; Yamazaki Y; Kawai T; Walter JE; Kondratenko IV; Šedivá A; van der Burg M; Kuzmenko NB; Notarangelo LD; Bernatowska E; Aleinikova OV
    Front Immunol; 2020; 11():900. PubMed ID: 32655540
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency.
    Felgentreff K; Perez-Becker R; Speckmann C; Schwarz K; Kalwak K; Markelj G; Avcin T; Qasim W; Davies EG; Niehues T; Ehl S
    Clin Immunol; 2011 Oct; 141(1):73-82. PubMed ID: 21664875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious and non-infectious complications in primary immunodeficiency disorders: an autopsy study from North India.
    Gupta K; Rawat A; Agrawal P; Jindal A; Nada R; Saikia B; Chan KW; Lau YL; Minz RW; Singh S
    J Clin Pathol; 2018 May; 71(5):425-435. PubMed ID: 28970295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
    Otsu M; Yamada M; Nakajima S; Kida M; Maeyama Y; Hatano N; Toita N; Takezaki S; Okura Y; Kobayashi R; Matsumoto Y; Tatsuzawa O; Tsuchida F; Kato S; Kitagawa M; Mineno J; Hershfield MS; Bali P; Candotti F; Onodera M; Kawamura N; Sakiyama Y; Ariga T
    J Clin Immunol; 2015 May; 35(4):384-98. PubMed ID: 25875699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency.
    Roifman CM; Zhang J; Chitayat D; Sharfe N
    Blood; 2000 Oct; 96(8):2803-7. PubMed ID: 11023514
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.